POPULAR SEARCHES
betabetadine-antiseptic-ointment-pvpi-10-with-box
Additional-pic-antiseptic-ointment

BETADINE®
Antiseptic Ointment
PVP-I 10%

BURNS CHRONIC WOUNDS
  • Proven effective to rapidly kill bacteria, viruses and fungi preventing topical wound infections.
  • Proven efficacy with wide spectrum of microbicidal activity.
  • Long lasting wound protection up to 48 hours.
  • Enhances wound healing in burns and chronic wounds.

How to use?

betadine-antiseptic-ointment-step-1

1

The affected skin should be
cleaned and dry1

betadine-antiseptic-ointment-step-2

2

Spread the BETADINE®
Ointment evenly over the area of
damaged skin1

betadine-antiseptic-ointment-step-3

3

If necessary, a dressing can be
applied1

RELATED PRODUCTS

BETADINE® Antiseptic Solution PVP-I 10%

BETADINE® Dry Powder Spray PVP-I 2.5%

WHERE TO BUY

Shop online

Shop products online

Shop in store

Locate a partner store near you

REFERENCES

  1. BETADINE® Ointment Insert Leaflet
  2. Mayer DA, et al. Povidone-Iodine and wound healing: A Critical Review. Wounds: A Compendium of Clinical Research and Practice. 1993; 5(1): 14-23.
  3. Remington "The Science & Practice of Pharmacy" 20th Ed, William K. Nichols, PhD. Anti-Infectives. Chapter 87-1516.
  4. Fleischer W, Reimer K. Povidone Iodine: in antisepsis-State of Art. Dermatology 1997;195 (suppl 2):3-9.
  5. M. Steen. Postgrad Med J 1993;69:S84-S92.
  6. Daroczy J. Title: Quality Control in chronic wound management: The role of local povidone (BETADINE®) therapy. Dermatology 2006; 212 (suppl 1): 82-87.
  7. Lachapelle JM, Castel O, Casado AF, et al. Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clin. Pract. (2013) 10(5), 579-592.
  8. Durani P, Leaper D. Povidone Iodine: use in hand disinfection, skin preparation and antiseptic irrigation. Int Wound J 2008;5:375-387.
  9. Reimer K, Schreier H, Erdos G, Konig W, Fleischer W. Molecular effects of a microbicidal substance on relevant microorganisms: electron microscopic and biochemical studies on Povidone-iodine. Zentralbi Hyg Umweltmed. 1998 Feb; 200(5-6):423-34.
  10. Russel, AD. Similarities and differences in the responses of microorganisms to biocides. J Antimicrobiol Chemo (2003) 52, 750-763.
  11. Rutala W, Weber D. The Healthcare Infection Control Practices Advisory Committee (HICPAC)
  12. Mcdonnell G, Russell AD. Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev. Jan. 1999. 147-179.
  13. Eming SA, et al. A novel property of povidone-iodine: inhibition of excessive protease levels in chronic non-healing wounds. J In Dermatol (2006) 126, 2731-2733.
  14. Kunisada T,Yamada K, Oda S and Hara O. Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology 1997; 195(suppl 2): 14-18.
  15. Hand, Foot and Mouth Disease Information Sheet. World Health Organization (Western Pacific Region). Available at http://www.wpro.who.int/emerging_diseases/hfmd.information.sheet/en. Accessed on 29/11/2016.
  16. Leyden J., Stewart R., et al. Updated in vivo Methods for Evaluating Topical Antimicrobial Agents on Human Skin. The Journal of Investigative Dermatology, Vol 72(4): 165-170, 1979

CONTRAINDICATIONS

  • BETADINE® Ointment is contraindicated for patients with hypersensitivity to iodine, hyperthyroidism.
  • Not to be used in children under 2 years of age.
  • During pregnancy and lactation, BETADINE® Ointment should only be used if strictly prescribed by a doctor and its use should be kept to an absolute minimum.

Please report any suspected Mundipharma Product or Device related adverse event or product complaint to: meadrugsafety@mundipharma.ae or contact +971 4 439 8777.

Consult your doctor / pharmacist before taking pharmaceutical products